[News Brief] Formosa Pharma Signs Licensing Deal With Samil Pharmaceutical
Formosa Pharmaceuticals, Inc. has entered into an exclusive licensing agreement with Samil Pharmaceutical Co., Ltd. for the commercialisation of an…
Formosa Pharmaceuticals, Inc. has entered into an exclusive licensing agreement with Samil Pharmaceutical Co., Ltd. for the commercialisation of an…
Mabwell has completed a dual primary listing on the Main Board of the Hong Kong Stock Exchange following its earlier…
LongBio Pharma has listed its shares on the Main Board of the Hong Kong Stock Exchange following its initial public…
Hanmi Pharmaceutical has entered into a supply agreement with Organon to export three combination medicines for the Malaysian and Philippine…
H. Lundbeck A/S has received marketing authorisation from South Korea’s Ministry of Food and Drug Safety (MFDS) for Vyepti (eptinezumab)…
Samsung Bioepis, a South Korea-based company, has launched its ustekinumab biosimilar in Japan through its partnership with Nipro Corporation, expanding…
South Korea-based Hyundai Bioscience has announced its readiness to supply its broad-spectrum antiviral drug XAFTY® in the event of Ebola…
Lotus Pharmaceutical, a Taiwan-based company, has entered into an agreement with OM Pharma to acquire the assets of a specialty…
China’s National Medical Products Administration (NMPA) has issued new implementation measures formalising protection for eligible undisclosed drug trial data submitted…
Suzhou Ribo Life Science Co., Ltd. and Insilico Medicine have entered into a strategic collaboration to integrate artificial intelligence platforms…